# Ranolazine a Potential New Therapeutic Application

> **NCT02687269** · PHASE4 · WITHDRAWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS**

## Conditions studied

- Myocardial Stunning

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02687269
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-04-10
- **Primary completion:** 2020-09
- **Final completion:** 2020-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to produce placebo tablets similar to the drug tested
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687269, "Ranolazine a Potential New Therapeutic Application". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02687269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*